Spots Global Cancer Trial Database for Chemotherapy Decisions and Outcomes in Older Women With Newly Diagnosed Breast Cancer
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Chemotherapy Decisions and Outcomes in Older Women With Newly Diagnosed Breast Cancer
Official Title: Observational Cohort Study: Chemotherapy Decisions and Outcomes in Women Age 65 or Older With Operable, Newly Diagnosed Breast Cancer
Study ID: NCT00068328
Study Description
Brief Summary: RATIONALE: Studying how older women make treatment decisions and how these decisions affect the outcome of treatment may help doctors plan more effective treatments and improve patient quality of life. PURPOSE: This clinical trial is studying how a patient's treatment preferences and decisions about chemotherapy affect the outcome of treatment in older women with newly diagnosed breast cancer.
Detailed Description: OBJECTIVES: * Determine the relationship between preferences and chemotherapy decisions in women age 65 and over with operable, newly diagnosed breast cancer. * Determine how factors that could be targets for intervention affect the relationship between preferences and chemotherapy decisions in these patients. * Determine the relationships between preference-based chemotherapy decisions, quality of life, and satisfaction with treatment decisions in these patients. * Determine the disease-free survival and competing causes of mortality of these patients. * Determine the types of physician providers who care for older breast cancer survivors after initial cancer treatment is completed and explore how women decide about which physicians to see. * Measure quality indicators for the survivorship phase of care and evaluate if quality varies by type of physician provider model. * Determine if long-term patient-reported satisfaction varies as a function of physician model for providing follow-up care post-treatment. * Determine whether physician-patient communication and coordination of care after treatment ends mediate follow-up quality and outcomes post-treatment. OUTLINE: This is a cohort study. Patients participate in interviews over 30-45 minutes at baseline, at 6 months, and at 1 and 2 years. Patients are followed annually for at least 5 years. PROJECTED ACCRUAL: A total of 1,296 patients will be accrued for this study within 18-24 months.
Eligibility
Minimum Age: 65 Years
Eligible Ages: OLDER_ADULT
Sex: FEMALE
Healthy Volunteers: No
Locations
Camino Medical Group - Treatment Center, Mountain View, California, United States
Palo Alto Medical Foundation, Palo Alto, California, United States
, Pismo Beach, California, United States
Bendheim Cancer Center at Greenwich Hospital, Greenwich, Connecticut, United States
Washington Cancer Institute at Washington Hospital Center, Washington, D.C., District of Columbia, United States
Walter Reed Army Medical Center, Washington, D.C., District of Columbia, United States
Cancer Center of South Florida Foundation, Incorporated, Lake Worth, Florida, United States
University of Chicago Cancer Research Center, Chicago, Illinois, United States
Louis A. Weiss Memorial Hospital, Chicago, Illinois, United States
La Grange Memorial Hospital, La Grange, Illinois, United States
Center for Cancer Care at OSF Saint Anthony Medical Center, Rockford, Illinois, United States
Elkhart Clinic, LLC, Elkhart, Indiana, United States
Michiana Hematology-Oncology, PC - Elkhart, Elkhart, Indiana, United States
Elkhart General Hospital, Elkhart, Indiana, United States
Howard Community Hospital, Kokomo, Indiana, United States
Center for Cancer Therapy at LaPorte Hospital and Health Services, La Porte, Indiana, United States
Suniti Medical Corporation, Merrillville, Indiana, United States
Michiana Hematology-Oncology, PC - South Bend, Mishawaka, Indiana, United States
Saint Joseph Regional Medical Center, Mishawaka, Indiana, United States
Michiana Hematology Oncology PC - Plymouth, Plymouth, Indiana, United States
CCOP - Northern Indiana CR Consortium, South Bend, Indiana, United States
Memorial Hospital of South Bend, South Bend, Indiana, United States
South Bend Clinic, South Bend, Indiana, United States
Michiana Hematology Oncology PC - La Porte, Westville, Indiana, United States
Maine Center for Cancer Medicine and Blood Disorders - Scarborough, Scarborough, Maine, United States
Harry and Jeanette Weinberg Cancer Institute at Franklin Square Hospital Center, Baltimore, Maryland, United States
Sturdy Memorial Hospital, Attleboro, Massachusetts, United States
Massachusetts General Hospital, Boston, Massachusetts, United States
Dana-Farber/Brigham and Women's Cancer Center, Boston, Massachusetts, United States
Dana-Farber/Harvard Cancer Center at Dana-Farber Cancer Institute, Boston, Massachusetts, United States
Addison Gilbert Hospital, Gloucester, Massachusetts, United States
Cape Cod Hospital, Hyannis, Massachusetts, United States
Lowell General Hospital, Lowell, Massachusetts, United States
Battle Creek Health System Cancer Care Center, Battle Creek, Michigan, United States
Mecosta County Medical Center, Big Rapids, Michigan, United States
Butterworth Hospital at Spectrum Health, Grand Rapids, Michigan, United States
CCOP - Grand Rapids, Grand Rapids, Michigan, United States
Lacks Cancer Center at Saint Mary's Health Care, Grand Rapids, Michigan, United States
Mercy General Health Partners, Muskegon, Michigan, United States
Michiana Hematology Oncology PC - Niles, Niles, Michigan, United States
Lakeland Regional Cancer Care Center - St. Joseph, Saint Joseph, Michigan, United States
Lakeside Cancer Specialists, PLLC, Saint Joseph, Michigan, United States
Munson Medical Center, Traverse City, Michigan, United States
Metro Health Hospital, Wyoming, Michigan, United States
Saint Luke's Hospital, Chesterfield, Missouri, United States
Ellis Fischel Cancer Center at University of Missouri - Columbia, Columbia, Missouri, United States
Siteman Cancer Center at Barnes-Jewish Hospital - Saint Louis, Saint Louis, Missouri, United States
St. Anthony's Cancer Center, Saint Louis, Missouri, United States
Saint Francis Cancer Treatment Center at Saint Francis Memorial Health Center, Grand Island, Nebraska, United States
Callahan Cancer Center at Great Plains Regional Medical Center, North Platte, Nebraska, United States
UNMC Eppley Cancer Center at the University of Nebraska Medical Center, Omaha, Nebraska, United States
University Medical Center of Southern Nevada, Las Vegas, Nevada, United States
CCOP - Nevada Cancer Research Foundation, Las Vegas, Nevada, United States
New Hampshire Oncology - Hematology, PA at Payson Center for Cancer Care, Concord, New Hampshire, United States
Center for Cancer Care at Exeter Hospital, Exeter, New Hampshire, United States
New Hampshire Oncology - Hematology, PA - Hooksett, Hooksett, New Hampshire, United States
Lakes Region General Hospital, Laconia, New Hampshire, United States
Norris Cotton Cancer Center at Dartmouth-Hitchcock Medical Center, Lebanon, New Hampshire, United States
Norris Cotton Cancer Center at Catholic Medical Center, Manchester, New Hampshire, United States
Elliot Regional Cancer Center at Elliot Hospital, Manchester, New Hampshire, United States
Foundation Medical Partners, Nashua, New Hampshire, United States
Oncology Center at St. Joseph Hospital, Nashua, New Hampshire, United States
St. Barnabas Medical Center Cancer Center, Livingston, New Jersey, United States
Roswell Park Cancer Institute, Buffalo, New York, United States
CCOP - Hematology-Oncology Associates of Central New York, East Syracuse, New York, United States
Queens Cancer Center of Queens Hospital, Jamaica, New York, United States
Memorial Sloan-Kettering Cancer Center, New York, New York, United States
Lipson Cancer and Blood Center at Rochester General Hospital, Rochester, New York, United States
Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill, Chapel Hill, North Carolina, United States
Duke Comprehensive Cancer Center, Durham, North Carolina, United States
Cape Fear Valley Medical Center Cancer Center, Fayetteville, North Carolina, United States
Maria Parham Medical Center, Henderson, North Carolina, United States
Southeastern Regional Medical Center, Lumberton, North Carolina, United States
Granville Medical Center, Oxford, North Carolina, United States
FirstHealth Moore Regional Community Hospital Comprehensive Cancer Center, Pinehurst, North Carolina, United States
Duke Health Raleigh Hospital, Raleigh, North Carolina, United States
Person Memorial Hospital, Roxboro, North Carolina, United States
Marion L. Shepard Cancer Center at Beaufort County Hospital, Washington, North Carolina, United States
Keyserling Cancer Center at Beaufort Memorial Hospital, Beaufort, South Carolina, United States
South Carolina Oncology Associates, PA, Columbia, South Carolina, United States
Coastal Cancer Center - Myrtle Beach, Myrtle Beach, South Carolina, United States
Mountainview Medical, Berlin Corners, Vermont, United States
Fletcher Allen Health Care - University Health Center Campus, Burlington, Vermont, United States
Medical Oncology and Hematology Associates of North Virginia - Fairfax, Fairfax, Virginia, United States
St. Mary's Regional Cancer Center at St. Mary's Medical Center, Huntington, West Virginia, United States
Contact Details
Name: Jeanne Mandelblatt, MD, MPH
Affiliation: Lombardi Comprehensive Cancer Center
Role: STUDY_CHAIR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
